Time:
0900 - 1030 PST
1700 - 1830 UTC
Zoom Meeting Details
Topic: SNOMED International Editorial Advisory Group
Time: Nov 27, 2023 09:00 Pacific Time (US and Canada)
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/84748079411?pwd=kc8eQuGjfPREpp89w0TOLlXiUvhJJ6.1
Password: 058419
Attendees
Chair:
AG Members:
Invitees:
Observers
Apologies:
Meeting Files:
Meeting minutes:
The call recording is located here.
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action |
|---|---|---|---|---|
| 1 | Call to order and role call | This meeting is being recorded to ensure that important discussion points are not missed in the minutes. The recording will be available to the SNOMED International community. Joining the meeting by accepting the Zoom prompt declares that you have no objection to your comments being recorded |
| |
| 2 | Conflicts of interest and agenda review | |||
| 3 | Modeling of "No known X" | Inconsistent representation of "No known...(situation)" with proposed remodeling. See attached document. Different resolution depending on whether the Situation is a "Finding with explicit context" (allowed range = << 410514004 |Finding context value (qualifier value)|) or a "Procedure with explicit context" (allowed range - << 288532009 |Context values for actions (qualifier value)|)? Discussion: Proposed definition for "No known" after consultation with EAG members. Differs from "unknown" in that it implies a reasonable effort to acquire the information, or a lack of evidence to support the issue at hand as opposed to a general lack of information for any reason. Agreed in the last meeting in Atlanta that it should be a sibling of "Unknown". Def: Decision: | ||
| MRCM change and revision of Physical object hierarchy |
Discussion: Decision: | |||
| Updating of Neuroendocrine tumors. Part of Histology update project | Briefing note describing the initial phase of the project to update the Neoplasm (morphologic abnormality) hierarchy to conform to the latest WHO Blue book. Discussion: Decision: | |||
| Inactivation of "Role groupers" from substances and products | Discussion on the briefing note to inactivate role groupers from Substance and Medicinal product (attached) Discussion: BN is a consultation. Do people use these role groupers? If not, are they aware of any other mechanism used to assign roles? (an example of a therapeutic role classification is ATC from WHO but others exist). High-level role groupers in the Substance hierarchy have been intended to support the organization of the hierarchy based on roles. An example of such a role grouper is 373265006 |Analgesic (substance)|. Substance role groupers have been an issue in SNOMED CT for many years. Role based groupers are associated with a particular purpose or outcome. A role does not belong to a substance per se but instead is associated with a manufactured product and its usage. Roles are a function of the way a product is formulated or presented. In 2018 a solution was proposed to move the role groupers from the Substances hierarchy to the Products hierarchy and specifically the “therapeutic roles” to the Medicinal Product hierarchy. While a small percentage (20%) of the role groupers have been created in the Medicinal product hierarchy (and often without subtypes being assigned, e.g. 53009005 |Medicinal product acting as analgesic agent (product)|), the majority of the role groupers remain in the Substances hierarchy at this time. Please provide feedback on the proposal. Send comments to (info@snomed.org ) by December 15th, 2023 with the heading attention of Nicki Ingram and Farzaneh Ashrafi. If further information is required the following 2 files can be forwarded by contacting info@snomed.org - attention of Nicki Ingram and Farzaneh Ashrafi : Once the feedback has been analysed then a further BN will be issued. Decision: | |||
| AOB | EAG | |||
| Next meeting | EAG | Meetings will continue on the fourth Monday of the month and may be cancelled if necessary. | ||